About SCIBASE AB
SciBase AB is a global medical technology company specializing in the early detection and prevention of skin cancer and other skin conditions. They develop and commercialize the Nevisense platform, a point-of-care technology that integrates artificial intelligence (AI) with Electrical Impedance Spectroscopy (EIS) to enhance diagnostic accuracy. This technology is designed to provide objective information to assist dermatologists and other clinicians in their decision-making processes for skin health management.
The Nevisense platform is utilized for various clinical applications, including the detection of melanoma and non-melanoma skin cancer, as well as for research in skin barrier assessment. The technology is built upon over two decades of research conducted at the Karolinska Institute in Stockholm, Sweden. SciBase aims to minimize patient suffering by enabling earlier, more accurate diagnoses and facilitating timely intervention, ultimately contributing to improved patient outcomes and reduced healthcare costs.
Focus Areas
Business Intelligence
| Technology | Nevisense, AI (artificial intelligence)/augmented intelligence, advanced EIS (Electrical Impedance Spectroscopy) technology, point-of-care platform |
What Physicians Need to Know
For physicians, SCIBASE AB's Nevisense platform offers a significant advancement in dermatological diagnostics by providing objective, non-invasive, and highly sensitive tools for early detection of skin cancer, particularly melanoma, where early detection is crucial for survival rates. The AI-powered EIS technology can enhance diagnostic accuracy and reduce unnecessary biopsies by providing data beyond visual inspection. Furthermore, its application in assessing skin barrier function can aid in the management of conditions like atopic dermatitis, allowing for more precise monitoring and intervention. The robust clinical data and FDA approval for melanoma detection provide a strong basis for its integration into clinical practice.
While the provided information does not detail specific EMR/EHR integrations, the Nevisense platform is a point-of-care device, suggesting a potential for streamlined workflow in a clinical setting. Physicians should inquire directly with SCIBASE AB regarding current or planned integrations with existing practice management and electronic health record systems for seamless data management and patient record keeping.
What the Web Says
SCIBASE AB is a Swedish medical technology company that develops AI-based diagnostic solutions for skin disorders, with its primary product being Nevisense, a tool to help doctors detect melanoma. While specific product reviews for Nevisense are not readily available on major review platforms like G2, Capterra, or Glassdoor under 'SCIBASE AB', the company is actively involved in collaborations and clinical trials to expand its product's applications. Employer reviews are also not widely found on the searched platforms directly for 'SCIBASE AB', though general mentions of the company's operations and board activities exist.
Overall: MixedStrengths
- Develops AI-based diagnostic solutions for skin disorders.
- Nevisense product aids in melanoma detection.
- Actively pursuing FDA approvals and expanded indications for its products.
- Collaborating with other companies in the healthcare sector to develop new diagnostic tests.
- Products are built on over 20 years of research.
Limitations
- Limited readily available product reviews on major platforms like G2, Capterra, and Glassdoor.
- Scarcity of direct employer reviews on platforms like Glassdoor.
- Some search results for 'Scibase' on review sites refer to different companies (e.g., Scibids, SciSpace, Spacebase, SubBase, CustomerBase, Scribe) which can cause confusion.
Based on reviews from: Physician AI Tools, Le Lézard, SciBase, Cision News, Inderes, PR Newswire, Capterra, G2
Last updated: 2026-10-21
Videos
News, demos, and interviews about SCIBASE AB.
Videos load interactively. If none appear, search YouTube for SCIBASE AB →
Press & Coverage
Frequently Asked Questions
Related Companies
The German Cancer Research Center (DKFZ) is the largest biomedical research institution in Germany and a leading international center for cancer research. Established in 1964, DKFZ is a member of the Helmholtz Association of German Research Centres. The center is dedicated to unraveling the causes and mechanisms of cancer development, identifying risk factors, and developing […]
aisencia GmbH is a healthcare AI company focused on revolutionizing diagnostic workflows in dermatopathology through artificial intelligence. They develop digital, AI-powered software solutions like Vistaneos and Cutaneos 80, designed to streamline pathology processes for faster, more precise, and accessible cancer diagnoses. The company’s technology aims to classify over 50 types of skin lesions, covering approximately […]
Autoderm is a health technology company that provides a CE-marked AI dermatology screening API designed to analyze smartphone photos for various skin conditions. The company’s AI models are trained on a proprietary database of amateur smartphone images of skin diseases and are accessible via an API that can be integrated into various platforms, including electronic […]
Skin Analytics is a British health technology company dedicated to the early and accurate diagnosis of skin cancer, aiming to reduce mortality from the disease. They achieve this through their flagship product, DERM, an AI-powered medical device. DERM is designed to provide dermatologist-quality skin cancer assessments, making them more accessible and reducing the burden on […]
AI Agent, specifically referring to the platform accessible via https://vertexaisearch.cloud.google.com, is now known as the Gemini Enterprise Agent Platform. This platform is Google Cloud’s comprehensive and open solution for building, deploying, scaling, governing, and optimizing production-grade AI agents. It provides a unified environment that integrates machine learning models, such as generative AI agents and search […]
The German Research Center for Artificial Intelligence (DFKI) is a leading research institution in Germany, established in 1988 as a non-profit public-private partnership. It focuses on intelligent software technologies, combining scientific excellence with societal relevance. DFKI conducts application-oriented basic research to develop product functions, prototypes, and patentable solutions in information and communication technology. The center’s […]